1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.2.1        Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Organization Size

1.2.2        Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Offering

1.2.3        Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Application

1.2.4        Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Clinical Indication

1.2.5        Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By End User

1.2.6        Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Geography

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Europe PEST Analysis

4.3         Experts Opinion

5.           In-Silico Trial Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Concerns Over Animal Welfare and Benefits

5.1.2        Insufficient Variable Patient Data and Limited Timescale

5.2         Market Restraints

5.2.1        Insufficient Variable Patient Data and Limited Timescale

5.3         Market Opportunities

5.3.1        Growing Applications of In-silico Trials in Radiology and Orthopedic Device Industry

5.4         Future Trends

5.4.1        Adoption of Artificial Intelligence in In-Silico Drug Discovery

5.5         Impact Analysis

6.           In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market– Europe Analysis

6.1         Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue Forecast and Analysis

7.           Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028– by Organization Size

7.1         Overview

7.2         Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, By Organization Size, 2020 & 2028 (%)

7.3         Large Organizations

7.3.1        Overview

7.3.2        Large Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 (US$ Million)

7.4         Small and Medium Organizations

7.4.1        Overview

7.4.2        Small and Medium Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 (US$ Million)

8.           In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 – Offering

8.1         Overview

8.2         Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

8.3         Products

8.3.1        Overview

8.3.2        Products: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

8.4         Platforms

8.4.1        Overview

8.4.2        Platforms: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

8.5         Services

8.5.1        Overview

8.5.2        Services: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

9.           In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 – Application

9.1         Overview

9.2         Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

9.3         Product Design and Discovery

9.3.1        Overview

9.3.2        Product Design and Discovery: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

9.4         Product Development

9.4.1        Overview

9.4.2        Product Development: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

9.5         Pre-Clinical Targeting

9.5.1        Overview

9.5.2        Pre-Clinical Targeting: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

9.6         Assessment of Drugs and Other Biomedical Products

9.6.1        Overview

9.6.2        Assessment of Drugs and Other Biomedical Products: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

9.7         Others (Optimization and Market Access)

9.7.1        Overview

9.7.2        Others (Optimization and Market Access): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10.        In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 – Clinical Indication

10.1      Overview

10.2      Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

10.3      Cardiovascular Disease

10.3.1     Overview

10.3.2     Cardiovascular Disease: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10.4      Neurodegenerative Disease

10.4.1     Overview

10.4.2     Neurodegenerative Disease: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10.5      Oncology

10.5.1     Overview

10.5.2     Oncology: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10.6      Rare Diseases

10.6.1     Overview

10.6.2     Rare Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10.7      Metabolic Diseases

10.7.1     Overview

10.7.2     Metabolic Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10.8      Immune Based Diseases

10.8.1     Overview

10.8.2     Immune Based Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10.9      Infectious Diseases

10.9.1     Overview

10.9.2     Infectious Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10.10   Others (Haematology, Diabetes, Dermatology)

10.10.1  Overview

10.10.2  Others (Haematology, Diabetes, and Dermatology): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

11.        In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 – End User

11.1      Overview

11.2      Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

11.3      Pharmaceutical and Biotechnology Companies

11.3.1     Overview

11.3.2     Pharmaceutical and Biotechnology Companies: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

11.4      Medical Technology Companies

11.4.1     Overview

11.4.2     Medical Technology Companies: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

11.5      Contract Research Organizations

11.5.1     Overview

11.5.2     Contract Research Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

11.6      Others (Universities and Research Centres)

11.6.1     Overview

11.6.2     Others (Universities and Research Centres): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

12.        In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 – Geographical Analysis

12.1      Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market

12.1.1     Overview

12.1.2     Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.3     Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

12.1.4     Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

12.1.4.1       Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.1.4.2       Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

12.1.4.3       Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

12.1.5     Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Country, 2021 & 2028 (%)

12.1.5.1       Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.1.1       Overview

12.1.5.1.2       Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.1.3       Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

12.1.5.1.4       Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

12.1.5.1.5       Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.1.5.1.6       Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

12.1.5.1.7       Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

12.1.5.2       France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.2.1       Overview

12.1.5.2.2       France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.2.3       France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

12.1.5.2.4       France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

12.1.5.2.5       France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.1.5.2.6       France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

12.1.5.2.7       France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

12.1.5.3       UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.3.1       Overview

12.1.5.3.2       UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.3.3       UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

12.1.5.3.4       UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

12.1.5.3.5       UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.1.5.3.6       UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

12.1.5.3.7       UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

12.1.5.4       Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.4.1       Overview

12.1.5.4.2       Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.4.3       Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

12.1.5.4.4       Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

12.1.5.4.5       Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.1.5.4.6       Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

12.1.5.4.7       Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

12.1.5.5       Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.5.1       Overview

12.1.5.5.2       Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.5.3       Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

12.1.5.5.4       Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

12.1.5.5.5       Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.1.5.5.6       Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

12.1.5.5.7       Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

12.1.5.6       Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.6.1       Overview

12.1.5.6.2       Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.5.6.3       Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

12.1.5.6.4       Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

12.1.5.6.5       Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.1.5.6.6       Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

12.1.5.6.7       Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

13.        In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market–Industry Landscape

13.1      Overview

13.2      Growth Strategies in the In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market (%)

13.3      Organic Developments

13.3.1     Overview

13.4      Inorganic Developments

13.4.1     Overview

14.        Company Profiles

14.1      InSilicoTrials Technologies

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      FEops

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      CADFEM Medical GmbH

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      Dassault Systèmes SE

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Virtonomy GmbH

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      Certara Inc.

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7      Computational Life

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8      Novadiscovery

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9      TwInsight Medical

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

14.10   Ansys, Inc.

14.10.1  Key Facts

14.10.2  Business Description

14.10.3  Products and Services

14.10.4  Financial Overview

14.10.5  SWOT Analysis

14.10.6  Key Developments

14.11   Synopsys, Inc.

14.11.1  Key Facts

14.11.2  Business Description

14.11.3  Products and Services

14.11.4  Financial Overview

14.11.5  SWOT Analysis

14.11.6  Key Developments

14.12   Sensyne Health plc.

14.12.1  Key Facts

14.12.2  Business Description

14.12.3  Products and Services

14.12.4  Financial Overview

14.12.5  SWOT Analysis

14.12.6  Key Developments

14.13   Cerner Corporation

14.13.1  Key Facts

14.13.2  Business Description

14.13.3  Products and Services

14.13.4  Financial Overview

14.13.5  SWOT Analysis

14.13.6  Key Developments

15.        Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms

LIST OF TABLES

Table 1.             Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

Table 3.             Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

Table 8.             Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 11.          France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

Table 12.          France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

Table 13.          France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 14.          France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

Table 15.          France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 16.          UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

Table 17.          UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

Table 18.          UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 19.          UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

Table 20.          UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

Table 23.          Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 24.          Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

Table 25.          Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 26.          Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

Table 27.          Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

Table 28.          Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 29.          Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

Table 30.          Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 31.          Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

Table 32.          Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

Table 33.          Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 34.          Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

Table 35.          Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 36.          Organic Developments in the In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market

Table 37.          Inorganic Developments in the In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market

Table 38.          Glossary of Terms

LIST OF FIGURES

Figure 1.           In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Segmentation

Figure 2.           Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Overview

Figure 3.           Large Organizations Segment Held Largest Share of Organization Size Segment in In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market

Figure 4.           UK is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, Industry Landscape

Figure 6.           Europe: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           In-Silico Trial Market: Impact Analysis of Drivers and Restraints

Figure 9.           Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.        Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size, 2020 & 2028 (%)

Figure 11.        Large Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        Small and Medium Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

Figure 14.        Products: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 15.        Platforms: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 16.        Services: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 17.        Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

Figure 18.        Product Design and Discovery: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19.        Product Development: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 20.        Pre-Clinical Targeting: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21.        Assessment of Drugs and Other Biomedical Products: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 22.        Others (Optimization and Market Access): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 23.        Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

Figure 24.        Cardiovascular Disease: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25.        Neurodegenerative Disease: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 26.        Oncology: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 27.        Rare Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 28.        Metabolic Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 29.        Immune Based Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 30.        Infectious Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 31.        Others (Hematology, Diabetes, and Dermatology): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 32.        Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

Figure 33.        Pharmaceutical and Biotechnology Companies: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 34.        Medical Technology Companies: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 35.        Contract Research Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 36.        Others (Universities and Research Centers): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 37.        Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Key Country – Revenue (2021) (US$ Million)

Figure 38.        Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

Figure 39.        Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Country, 2021 & 2028 (%)

Figure 40.        Germany: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41.        France: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42.        UK: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43.        Italy: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

Figure 44.        Spain: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

Figure 45.        Rest of Europe: In Silico: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

Figure 46.        Growth Strategies in the In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market (%)